BACKGROUND: High pulse pressure (PP) is associated with cardiovascular events, but subclinical abnormalities in cardiac structure and function in relation to high pulse pressure are not well described. METHODS AND RESULTS: 2225 hypertensive and 1380 non-hypertensive participants with adequate echocardiographic left ventricular measurements were evaluated. Non-hypertensives in the highest PP tertile (compared to the lower tertiles) were older (44 years vs. 40 years, p<0.009), had higher systolic pressure [(SBP) 136 mmHg vs. 108 mmHg] and lower diastolic pressure [(DBP) 54 vs. 71 mmHg (p=.0001)], greater BMI (27 vs. 25 kg/m2, p<.001) and more diabetes (4% vs. 2.25%, p<.001). In the hypertensive group, subjects in the highest PP tertile were older (52 vs 42 years), had higher SBP (157 vs. 116 mmHg) but lower DBP (65 vs. 83 mmHg). In the non-hypertensive group, higher PP (>60 mmHG) was associated with a higher frequency of echocardiographic structural and functional abnormalities, specifically, greater posterior and relative wall thickness, longer isovolumic relaxation time, and concentric left ventricular (LV) hypertrophy. CONCLUSION: In a population-based sample of hypertensive and non-hypertensive participants, higher PP was associated with subclinical abnormalities of cardiac structure and function, which exist even in the absence of hypertension and/or the use of antihypertensive treatment.
BACKGROUND: High pulse pressure (PP) is associated with cardiovascular events, but subclinical abnormalities in cardiac structure and function in relation to high pulse pressure are not well described. METHODS AND RESULTS: 2225 hypertensive and 1380 non-hypertensiveparticipants with adequate echocardiographic left ventricular measurements were evaluated. Non-hypertensives in the highest PP tertile (compared to the lower tertiles) were older (44 years vs. 40 years, p<0.009), had higher systolic pressure [(SBP) 136 mmHg vs. 108 mmHg] and lower diastolic pressure [(DBP) 54 vs. 71 mmHg (p=.0001)], greater BMI (27 vs. 25 kg/m2, p<.001) and more diabetes (4% vs. 2.25%, p<.001). In the hypertensive group, subjects in the highest PP tertile were older (52 vs 42 years), had higher SBP (157 vs. 116 mmHg) but lower DBP (65 vs. 83 mmHg). In the non-hypertensive group, higher PP (>60 mmHG) was associated with a higher frequency of echocardiographic structural and functional abnormalities, specifically, greater posterior and relative wall thickness, longer isovolumic relaxation time, and concentric left ventricular (LV) hypertrophy. CONCLUSION: In a population-based sample of hypertensive and non-hypertensiveparticipants, higher PP was associated with subclinical abnormalities of cardiac structure and function, which exist even in the absence of hypertension and/or the use of antihypertensive treatment.
Entities:
Keywords:
Left ventricular hypertrophy; arterial stiffness; echocardiography; hypertension; pulse pressure
Authors: R B Devereux; M J Roman; M Paranicas; M J O'Grady; E A Wood; B V Howard; T K Welty; E T Lee; R R Fabsitz Journal: Am J Hypertens Date: 1997-06 Impact factor: 2.689
Authors: K Wachtell; J Rokkedal; J N Bella; T Aalto; B Dahlöf; G Smith; M J Roman; H Ibsen; G P Aurigemma; R B Devereux Journal: Am J Cardiol Date: 2001-01-01 Impact factor: 2.778
Authors: V Palmieri; B Dahlöf; V DeQuattro; N Sharpe; J N Bella; G de Simone; M Paranicas; D Fishman; R B Devereux Journal: J Am Coll Cardiol Date: 1999-11-01 Impact factor: 24.094
Authors: W G Hundley; D W Kitzman; T M Morgan; C A Hamilton; S N Darty; K P Stewart; D M Herrington; K M Link; W C Little Journal: J Am Coll Cardiol Date: 2001-09 Impact factor: 24.094
Authors: Daniel A Duprez; Daniel R Kaiser; Wayne Whitwam; Stanley Finkelstein; Andres Belalcazar; Robert Patterson; Stephen Glasser; Jay N Cohn Journal: Am J Hypertens Date: 2004-08 Impact factor: 2.689
Authors: T K Welty; E T Lee; J Yeh; L D Cowan; O Go; R R Fabsitz; N A Le; A J Oopik; D C Robbins; B V Howard Journal: Am J Epidemiol Date: 1995-08-01 Impact factor: 4.897
Authors: Kirstie A De Jong; Juliane K Czeczor; Smithamol Sithara; Kevin McEwen; Gary D Lopaschuk; Alan Appelbe; Kimberly Cukier; Mark Kotowicz; Sean L McGee Journal: Cardiovasc Diabetol Date: 2017-02-08 Impact factor: 9.951